Tuesday, May 31, 2016

Lipocine advancing pipeline, PDUFA for oral TRT

Lipocine advancing pipeline, PDUFA for oral TRT

May 31, 2016 by · Leave a Comment 

Tweet With a PDUFA date of June 28 for an FDA decision on its oral testosterone replacement therapy (TRT) product candidate, TLANDO, Lipocine’s (NASDAQ:LPCN) next two pipeline product candidates are advancing towards Phase 3 ready status this year. “We have a robust pipeline with a number of key milestones in 2016 besides the decision on […]

Delivra implementing U.S. expansion strategy for topical creams

Delivra implementing U.S. expansion strategy for topical creams

May 24, 2016 by · Leave a Comment 

Tweet The major initiative for Delivra (TSX-V:DVA) in 2016 is to introduce its flagship LivRelief topical pain and nerve creams to the U.S. market, initially through a U.S. web store and Amazon, and then through regional and national retailers, such as Walmart, Walgreens and CVS. “We are launching an aggressive digital campaign shortly, and later […]

ARIAD hopes to launch second oncology drug in early 2017

ARIAD hopes to launch second oncology drug in early 2017

May 17, 2016 by · Leave a Comment 

Tweet ARIAD Pharmaceuticals (NASDAQ:ARIA) is hoping to receive FDA approval to commercialize in early 2017 its second orphan oncology product, brigatinib, for the treatment of certain genetic forms of non-small cell lung cancer. At the end of 2012, the company launched Iclusig (ponatinib) to treat patients with several genetic types of chronic myeloid leukemia. “As […]

In conversation with Rosario G. Cartagena

In conversation with Rosario G. Cartagena

May 10, 2016 by · Leave a Comment 

Tweet As a member of the Health Law Group at Fasken Martineau in Toronto, Rosario Cartagena provides advice on a variety of health law matters, including corporate governance, public policy, government relations, risk management, privacy, health regulatory compliance, and health research. She also regularly assists in drafting agreements, related to corporate governance and regulatory compliance across […]

Profound Medical readies pivotal clinical trial of TULSA-PRO

Profound Medical readies pivotal clinical trial of TULSA-PRO

May 3, 2016 by · Leave a Comment 

http://www.youtube.com/watch?v=Wyy5jLOi8ac’]

Tweet After receiving CE Mark approval last month of its minimally invasive transurethral ultrasound technology for the ablation of benign and malignant prostate tissue, known as TULSA-PRO, Profound Medical (TSX-V:PRN) plans to enroll 14 sites in the U.S., Canada and Europe in a pivotal trial for U.S. regulatory approval. “We have discussions ongoing with the […]

In conversation with Paul Gunn

In conversation with Paul Gunn

April 26, 2016 by · Leave a Comment 

http://www.youtube.com/watch?v=Acau04X2Utk’]

Tweet As president and CEO of closely-held Soricimed Biopharma, Paul Gunn parlayed a 20-year career as a financial executive into funding the startup of Soricimed along with a tech transfer in 2005 facilitated by Mount Allison University in Sackville, New Brunswick, Canada. Admittedly, he was new to biotech and drug development in those days, but […]

Xagenic readies X1 molecular diagnostic beta trials

Xagenic readies X1 molecular diagnostic beta trials

April 19, 2016 by · Leave a Comment 

Tweet Closely-held Xagenic plans to conduct beta studies this year, in advance of a major chlamydia and gonorrhea clinical trial, with its rapid X1 molecular diagnostic testing system in preparation for market launches in Europe and the U.S. “The Xagenic X1 platform is a revolutionary diagnostic sys­tem that allows the user to perform lab-quality molecular […]

In conversation with Jerry Ropelato

In conversation with Jerry Ropelato

April 12, 2016 by · Leave a Comment 

http://www.youtube.com/watch?v=1Ak-sISGgn8′]

Tweet As CEO and founder of closely-held WhiteClouds, which operates the largest 3D color printing facility in the world, Jerry Ropelato is passionate about using the technology to create stunning models for the architecture, entertainment, retail and medical sectors. He points out that 3D printing is helping to further personalize healthcare and can play a […]

Microbix validating new virology production process

Microbix validating new virology production process

April 5, 2016 by · Leave a Comment 

Tweet Microbix Biosystems (TSX:MBX) is validating a new bioreactor manufacturing platform for its world-leading line of viral and bacterial antigens and other virology products ahead of a full roll-out to customers towards the end of 2016. “Once the new platform is fully implemented, it will reduce our manufacturing costs, greatly expand our available capacity and […]

Pivot Pharma seeks financing to develop drugs for women’s cancers

Pivot Pharma seeks financing to develop drugs for women’s cancers

March 29, 2016 by · Leave a Comment 

Tweet Upstart Pivot Pharmaceuticals (OTCQB:PVOTF), which was launched in the fourth quarter last year, is in talks with investors to raise up to $8-million in 2016 to initiate proof-of-concept studies for one of its two lead drug candidates for the treatment of endometrial and triple-negative breast cancers. “These women’s cancers represent areas of high unmet […]

Next Page »

Email Newsletters with Constant Contact
Google+